Catherine Ramsay1, Christiane Mallett1,
  Paula Foster1
1Imaging, Robarts Research Institute,
  London, ON, Canada
The
  purpose of this study was to test a new commercially available SPIO which has
  a colloidal size of 50 nm, a zeta potential of +31 mV and which is
  cross-linked with a rhodamine B label. Here we show that a variety of cell
  lines (lymphocytes, cancer and stem cells) can be labeled with this agent
  (MoldayION Rhodamine B, BioPal Inc), by simple co-incubation, without the use
  of transfection agents, at a level that permits their detection by MRI and
  without affecting cell viability. This
  is illustrated using iron staining of cells, fluorescence microscopy,
  electron microscopy and cellular MRI.
Keywords